Project Grant K08HS029530
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$308K
Funding Federal Agency
Office of Extramural Research Education and Priority Populations
Awarding Federal Agency
Division of Grants Management
Federal Grant Program
93.226
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This federal Project Grant award of $500,000.00 was made on September 30, 2024 by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program. The grant was awarded to Brigham & Women's Hospital Inc., a subsidiary of the larger Partners Healthcare System Incorporated, to conduct research on the relationships between diagnosis quality, clinician time and stress. The key objectives of the 4-year project are to: 1)...
This $968,999 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support a study to optimize imaging-based surveillance for lung cancer survivors treated with curative-intent surgery. The primary objectives are to: 1) determine real-world patterns and effectiveness of imaging surveillance, 2) develop and validate risk prediction models for lung cancer recurrence and second primary lung cancer using imaging biomarkers from...
This $1,473,750 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research study on "The Immunomodulatory Impact of Chemotherapy When Combined with PD-1 Blockade in Resectable Lung Cancer." The 3-year grant, running from September 1, 2024 to August 31, 2027, aims to investigate innovative immunological interventions for treating lung cancer in military service...
This federal Project Grant award, valued at $853,312.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by The Johns Hopkins University to detect pulmonary stromal premetastatic niches for early monitoring of post-surgery metastatic risk. The research aims to transform healthcare for military service members and the general public through innovative approaches to disease prevention, diagnosis, and...
The U.S. National Cancer Institute (NCI) awarded a $158,290 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Kaiser Foundation Hospitals to conduct a study on "Estimating Overdiagnosis After Implementation of Lung Cancer Screening in Community-Based Healthcare Systems." This 2-year project, running from July 2024 to July 2026, aims to produce estimates of overdiagnosis among patients diagnosed with lung cancer who participated in lung cancer...
This $205,418 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) aims to analyze differences in patient-level factors associated with payment pathways for molecular diagnostics (MDx) and define institution-level resources that promote access to MDx payment pathways. The study will focus on a case study of circulating tumor DNA (ctDNA) testing for lung cancer patients. Key objectives include identifying and prioritizing institution-level...
This $306,999 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) is focused on developing an integrated machine learning framework to accurately identify lung cancer subtypes. The key products and services to be delivered include: Establishing a gene signature-transfer machine learning model that leverages large-scale bulk and single-cell transcriptomics data, both within and beyond NIH Common Fund...
This $566,523 Project Grant awarded by the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports research to identify interception targets for lung cancer prevention. The primary awardee, The Regents of the University of Colorado (University of Colorado-Denver), will use an innovative reverse translational approach to investigate mechanisms driving persistence of precancerous lung lesions and determine how prevention agents like...
This federal Project Grant award, valued at $234,730.00, was provided by the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The funding supports research to define the transcriptional and epigenetic signatures in normal lung tissue that predispose to lung cancer development, as well as the molecular phenotypes of resulting lung tumors in a mouse model. The central hypothesis is that preexisting epigenetic perturbations in lung tissue...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the Cardiovascular Diseases Research (CFDA 93.837) federal grant program, aims to leverage quantitative imaging data from lung cancer screening to develop tools for detecting chronic obstructive pulmonary disease (COPD). The $626,247 award to the Regents of the University of Michigan will fund research to: 1) characterize COPD-related pathology from lung cancer screening CT scans, and 2) build a...